login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VIKING THERAPEUTICS INC (VKTX) Stock News
USA
- NASDAQ:VKTX -
US92686J1060
-
Common Stock
38.08
USD
-0.09 (-0.24%)
Last: 10/31/2025, 8:18:34 PM
38.18
USD
+0.1 (+0.26%)
After Hours:
10/31/2025, 8:18:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VKTX Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Chartmill
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline
a day ago - By: The Motley Fool
- Mentions:
CAVA
FIG
3 Promising Growth Stocks That Are Down Around 60% From Their Highs
a day ago - By: Stocktwits
- Mentions:
MTSR
NVO
PFE
LLY
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
2 days ago - By: Benzinga
- Mentions:
RDNT
BMY
DHR
LLY
...
10 Health Care Stocks Whale Activity In Today's Session
2 days ago - By: Stocktwits
- Mentions:
MTSR
NVO
PFE
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
3 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
5 days ago - By: Zacks Investment Research
Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?
9 days ago - By: Zacks Investment Research
- Mentions:
ALNY
ALKS
HOWL
Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil
9 days ago - By: The Motley Fool
Here's Why This Obesity Drug Company's Share Price Soared Today
9 days ago - By: Benzinga
Why Is Viking Therapeutics Stock Rising Today?
9 days ago - By: Stocktwits
- Mentions:
QUSA
ITOT
MS
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside
9 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
NVO
LLY
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
9 days ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?
9 days ago - By: Investor's Business Daily
- Mentions:
LLY
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies
10 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
15 days ago - By: Zacks Investment Research
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
17 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025
a month ago - By: Stocktwits
- Mentions:
LLY
PFE
MTSR
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
a month ago - By: Zacks Investment Research
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know
a month ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
Can NVO Maintain Obesity Leadership With Next-Generation Candidates?
Please enable JavaScript to continue using this application.